MY124714A - Enzyme treatment - Google Patents

Enzyme treatment

Info

Publication number
MY124714A
MY124714A MYPI20005779A MYPI20005779A MY124714A MY 124714 A MY124714 A MY 124714A MY PI20005779 A MYPI20005779 A MY PI20005779A MY PI20005779 A MYPI20005779 A MY PI20005779A MY 124714 A MY124714 A MY 124714A
Authority
MY
Malaysia
Prior art keywords
enzymes
enzyme treatment
treatment
effiency
cleave
Prior art date
Application number
MYPI20005779A
Other languages
English (en)
Inventor
M Anderson David
Liu Lin
Hsiao Humg-Yu
W Fodge Douglas
Original Assignee
Elanco Us Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22617824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY124714(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Elanco Us Inc filed Critical Elanco Us Inc
Publication of MY124714A publication Critical patent/MY124714A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/04—Phosphoric diester hydrolases (3.1.4)
    • C12Y301/04011—Phosphoinositide phospholipase C (3.1.4.11)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
MYPI20005779A 1999-12-10 2000-12-08 Enzyme treatment MY124714A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16993599P 1999-12-10 1999-12-10

Publications (1)

Publication Number Publication Date
MY124714A true MY124714A (en) 2006-06-30

Family

ID=22617824

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20005779A MY124714A (en) 1999-12-10 2000-12-08 Enzyme treatment

Country Status (31)

Country Link
US (2) US6780628B2 (h)
EP (1) EP1239872B1 (h)
JP (1) JP4871473B2 (h)
KR (1) KR100639746B1 (h)
CN (3) CN1433319A (h)
AR (2) AR026764A1 (h)
AT (1) ATE481981T1 (h)
AU (1) AU782831B2 (h)
BR (1) BRPI0016231B8 (h)
CA (1) CA2394856C (h)
CL (1) CL2008000057A1 (h)
CO (1) CO5280226A1 (h)
CR (1) CR6674A (h)
CZ (1) CZ304925B6 (h)
DE (1) DE60045010D1 (h)
DK (1) DK1239872T3 (h)
ES (1) ES2353371T3 (h)
HU (1) HU230301B1 (h)
IL (2) IL150048A0 (h)
IN (1) IN247731B (h)
MX (1) MX264033B (h)
MY (1) MY124714A (h)
NZ (1) NZ519404A (h)
PH (1) PH12000003381B1 (h)
PL (1) PL203054B1 (h)
PT (1) PT1239872E (h)
RU (1) RU2272419C2 (h)
SK (1) SK287956B6 (h)
TW (1) TWI255189B (h)
UA (1) UA78486C2 (h)
WO (1) WO2001041785A2 (h)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78486C2 (uk) 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
US7247299B2 (en) * 2002-11-27 2007-07-24 Kemin Industries, Inc. Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens
US7566447B2 (en) * 2003-05-15 2009-07-28 Iogenetics, Llc Biocides
US8703134B2 (en) 2003-05-15 2014-04-22 Iogenetics, Llc Targeted cryptosporidium biocides
US20050014932A1 (en) * 2003-05-15 2005-01-20 Iogenetics, Llc Targeted biocides
US8394379B2 (en) * 2003-05-15 2013-03-12 Iogenetics, Llc Targeted cryptosporidium biocides
US8710012B2 (en) 2003-07-14 2014-04-29 Cls Therapeutics Limited Method for treating oncological diseases
US8431123B2 (en) 2003-07-14 2013-04-30 Cls Therapeutics Limited Method for treating systemic bacterial, fungal and protozoan infection
US8388951B2 (en) 2003-07-14 2013-03-05 Cls Therapeutics Limited Method for treating systemic DNA mutation disease
US20080274095A1 (en) * 2004-10-20 2008-11-06 Jane Homan Biocides
EP1880733A4 (en) 2005-04-25 2009-08-12 Genkin Dmitry Dmitrievich METHOD FOR EXTENDING THE LIFE OF A HUMAN AND ANIMALS
ES2361819T3 (es) 2005-12-15 2011-06-22 Chemgen Corporation Enzimas para reducir el estrés inmunológico.
AU2007208138B2 (en) * 2006-01-23 2011-06-02 Hill's Pet Nutrition, Inc. Methods for reducing food intake and controlling the weight of animals
RU2319481C1 (ru) * 2006-10-20 2008-03-20 Илья Николаевич Медведев Способ коррекции уровня оксида азота в крови поросят с острым катаральным энтеритом
EP2095825B8 (de) 2006-11-28 2012-03-28 CLS Therapeutics Limited Verfahren zur behandlung von krankheiten des menschen im zusammenhang mit einem erhöhten desoxyribonucleinsäuregehalt in extrazellulären räumen von geweben und medizinische zubereitung zur durchführung des verfahrens
EP2980100A1 (en) * 2007-06-08 2016-02-03 Australian Poultry CRC Pty Ltd Clostridial toxin netb
RU2440369C2 (ru) * 2007-08-03 2012-01-20 Бёрингер Ингельхайм Ветмедика Гмбх ГЕНЫ И БЕЛКИ Brachyspira hyodysenteriae И ИХ ПРИМЕНЕНИЕ
EP2225356B1 (en) * 2007-12-20 2014-08-20 Danisco US Inc. Enzymatic prevention and control of biofilm
JP6047273B2 (ja) * 2008-02-08 2016-12-21 プロセラ インコーポレイテッド 胃腸のバイオフィルムの抑制および治療
RU2380901C1 (ru) * 2008-08-13 2010-02-10 Государственное научное учреждение Ставропольский научно-исследовательский институт животноводства и кормопроизводства Российской академии сельскохозяйственных наук Способ повышения однородности стада, живой массы, конверсии корма при выращивании цыплят
CN105925548A (zh) 2012-02-16 2016-09-07 伊莱利利公司 用于减少动物废物的环境影响的方法和组合物
US10617743B2 (en) 2014-06-19 2020-04-14 Cls Therapeutics Limited Method to improve safety and efficacy of anti-cancer therapy
TWI656872B (zh) 2014-11-13 2019-04-21 美商益農美國公司 甲基鹽黴素於豬飼料中之抗病毒效果
JP6745873B2 (ja) 2015-05-22 2020-08-26 ドミトリエヴィッチ ゲンキン，ドミトリー 神経変性における治療標的としての細胞外ｄｎａ
CN106119221A (zh) * 2016-06-28 2016-11-16 浙江省农业科学院 磷脂酰肌醇特异性磷脂酶c基因、载体、工程菌及应用
CN106318925B (zh) * 2016-08-19 2021-04-02 浙江省农业科学院 利用枯草芽孢杆菌高效表达pi-plc基因的方法
CN106615691B (zh) * 2016-10-11 2019-07-02 上海国龙生物技术集团有限公司 一种抗感染酶复合剂及其在饲料中的应用
US10501730B2 (en) * 2017-05-30 2019-12-10 Ab Enzymes Oy Mannanase variants
CA3088723A1 (en) 2018-01-16 2019-07-25 Cls Therapeutics Limited Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (dnase) activity
KR20200128413A (ko) * 2018-03-02 2020-11-12 에보니크 오퍼레이션즈 게엠베하 오보트랜스페린을 결정함으로써 동물에서의 장 장벽 기능상실을 검출하기 위한 시험관내 방법
RU2720471C1 (ru) * 2019-03-21 2020-04-30 Федеральное Государственное бюджетное научное учреждение "Федеральный научный центр биологических систем и агротехнологий российской академии наук" Кормовая добавка для цыплят-бройлеров

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
JPS5534039A (en) 1978-08-30 1980-03-10 Hiroo Ikezawa Preparation of phsophatidylinositol phospholipase c from bacillus thuringiensis
WO1987000196A1 (en) 1985-07-09 1987-01-15 Quadrant Bioresources Limited Protection of proteins and the like
US5049379A (en) 1987-07-27 1991-09-17 Wisconsin Alumni Research Foundation Fungicidal toxin and method and inoculum for controlling root rot and damping off
US4877738A (en) 1986-07-25 1989-10-31 Wisconsin Alumni Research Foundation Biological control of damping off and root rot and inoculum preparation therefor
JPH0338530A (ja) * 1989-07-03 1991-02-19 Ajinomoto Co Inc 抗真菌剤
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
JP3608620B2 (ja) * 1990-05-29 2005-01-12 ケムジエン・コーポレイシヨン ヘミセルロース含有食品及び動物用飼料のエネルギー効率を改善するためのヘミセルラーゼ補充物
EP0477739A3 (en) 1990-09-27 1992-12-09 F. Hoffmann-La Roche Ag Glycosyl-phosphatidylinositol-specific phospholipase d
CA2114122A1 (en) * 1991-07-24 1993-02-04 Thomas Sai Ying Ko Therapeutic compositions and methods
JPH07184642A (ja) * 1993-12-27 1995-07-25 Toagosei Co Ltd ホスホリパーゼｃの生産方法
MY134684A (en) 1995-05-15 2007-12-31 Gist Brocades Bv Application of phospholipases in animal feed
EP0743017B1 (en) * 1995-05-15 2004-09-29 DSM IP Assets B.V. Application of phospholipases in animal feed
JPH08332032A (ja) * 1995-06-12 1996-12-17 Showa Denko Kk 動物経口物用酵素剤及びその用途
JP3914585B2 (ja) * 1995-10-19 2007-05-16 イーエヌ大塚製薬株式会社 マクロファージ一酸化窒素産生亢進剤
US6162473A (en) * 1996-05-03 2000-12-19 Chemgen Corporation Hemicellulase use in feeds with low caloric content
CN1092495C (zh) 1996-05-03 2002-10-16 开姆根有限公司 半纤维素酶在低热焓饲料中的应用
JPH1045581A (ja) * 1996-07-29 1998-02-17 Hideyo Yamaguchi 好中球機能低下抑制剤又は感染防御剤
EP0948608A1 (en) * 1996-10-31 1999-10-13 Novo Nordisk A/S Novel phospholipase, production and use thereof
TR200101074T2 (tr) * 1998-10-15 2001-09-21 Dsm N.V. Hayvan yeminde antimikrobik enzimler
UA78486C2 (uk) 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
US20020116028A1 (en) * 2001-02-20 2002-08-22 Wilson Greatbatch MRI-compatible pacemaker with pulse carrying photonic catheter providing VOO functionality

Also Published As

Publication number Publication date
CN101327320A (zh) 2008-12-24
CA2394856A1 (en) 2001-06-14
JP4871473B2 (ja) 2012-02-08
HUP0203402A3 (en) 2004-12-28
JP2003520207A (ja) 2003-07-02
CN102172262B (zh) 2014-03-05
PT1239872E (pt) 2010-12-03
KR20020069204A (ko) 2002-08-29
ES2353371T3 (es) 2011-03-01
CN1433319A (zh) 2003-07-30
BR0016231A (pt) 2003-06-24
KR100639746B1 (ko) 2006-10-30
CZ304925B6 (cs) 2015-01-28
IN2002DE00585A (h) 2009-03-20
NZ519404A (en) 2004-05-28
EP1239872B1 (en) 2010-09-22
HUP0203402A2 (hu) 2003-02-28
AR026764A1 (es) 2003-02-26
CA2394856C (en) 2011-05-10
WO2001041785A3 (en) 2002-01-24
WO2001041785A2 (en) 2001-06-14
BRPI0016231B8 (pt) 2021-05-25
PL203054B1 (pl) 2009-08-31
HU230301B1 (hu) 2015-12-28
RU2272419C2 (ru) 2006-03-27
CN102172262A (zh) 2011-09-07
IL150048A (en) 2016-09-29
PH12000003381B1 (en) 2010-04-16
US6780628B2 (en) 2004-08-24
IL150048A0 (en) 2002-12-01
MXPA02005735A (es) 2003-10-14
DE60045010D1 (de) 2010-11-04
EP1239872A2 (en) 2002-09-18
ATE481981T1 (de) 2010-10-15
CR6674A (es) 2007-02-22
US20040223961A1 (en) 2004-11-11
AR089799A2 (es) 2014-09-17
SK8262002A3 (en) 2002-12-03
SK287956B6 (sk) 2012-07-03
CL2008000057A1 (es) 2008-03-14
BRPI0016231B1 (pt) 2016-10-04
US20020048576A1 (en) 2002-04-25
IN247731B (h) 2011-05-13
CZ20022007A3 (cs) 2002-11-13
AU782831B2 (en) 2005-09-01
MX264033B (es) 2009-01-22
DK1239872T3 (da) 2010-10-25
US7723091B2 (en) 2010-05-25
CO5280226A1 (es) 2003-05-30
UA78486C2 (uk) 2007-04-10
TWI255189B (en) 2006-05-21
PL356175A1 (en) 2004-06-14
AU2577601A (en) 2001-06-18

Similar Documents

Publication Publication Date Title
MY124714A (en) Enzyme treatment
MY128071A (en) Method for improving the skin and coat of pets
NZ511870A (en) Method for increasing pet activity
WO2000015202A3 (de) Topisch anwendbare mittel
WO2005000161A3 (en) Methods and devices for occluding body lumens and/or for delivering therapeutic agents
TR200103606T2 (tr) Laktik Asit Bakterisi Kombinasyonu ve Kullanımı
IL150818A0 (en) Composition for intestinal delivery
PT983076E (pt) Microrganismos de degradação de oxalato ou enzimas de degradação de oxalato para prevenir doenças relacionadas com oxalato
SI1181047T2 (sl) Zmes, ki vsebuje alkalično sfinhomielinazo za uporabo kot dietetični preparat, dodatek jedem ali kot farmacevtski proizvod
SI1951290T1 (en) A device for use in the case of fructose intolerance
CA2335308A1 (en) Protease containing hairball remedy and use thereof
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
WO1999012552A8 (en) 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
AU5277000A (en) Stimulating transport of glucose into animal tissue by the administration of pinitol
YU14700A (sh) UPOTREBA 8a-AZALIDA U VETERINI KAO ANTIMIKROBNA SREDSTVA
GB2377638B (en) Treatment of infection in animals
WO2000064417A3 (en) Inactivated microorganisms comprising substances having pharmacological activity
IL110888A0 (en) Pharmaceutical compositions for the treatment of liver diseases comprising a benzothiazepine derivative
UA40775A (uk) Сорбційна присипка
UA40749A (uk) Препарат для лікування затримки посліду і ендометритів у корів - "ендосан"
EP1779853A3 (en) 9a-azalides as veterinary antimicrobial agents
UA36030A (uk) Препарат для лікування і профілактики респіраторних хвороб коней " сегп "
TH54151A (th) องค์ประกอบซึ่งประกอบรวมด้วยเอนไซม์สำหรับรักษาการติดเชื้อของทางเดินอาหาร